Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway

2019

Background Carfilzomib (CFZ), a proteasome inhibitor approved by the FDA to treat multiple myeloma, may cause nephrotoxicity.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

51

References

15

Citations